In the Paediatric AIDS Clinical Trials Group (PACTG) 219 study, 33% of children who initiated treatment with CD4<5% reached normal levels after three years of treatment, compared to 45% after four years in our study [26]. This evidence concerns the gene CD4 and AIDS.